We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

188 hedge funds and large institutions have $2.57B invested in Audentes Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more funds holding in top 10

Funds holding in top 10: 3 → 19 (+16)

105% more capital invested

Capital invested by funds: $1.25B → $2.57B (+$1.32B)

87% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 46

26% more funds holding

Funds holding: 149 → 188 (+39)

21% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 39

85% less call options, than puts

Call options by funds: $12.5M | Put options by funds: $82.4M

Holders
188
Holders Change
+39
Holders Change %
+26.17%
% of All Funds
3.7%
Holding in Top 10
19
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+533.33%
% of All Funds
0.37%
New
86
Increased
47
Reduced
39
Closed
46
Calls
$12.5M
Puts
$82.4M
Net Calls
-$69.9M
Net Calls Change
-$68.8M

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$59.8M
2
AAM
Alpine Associates Management
Florida
+$54.6M
3
AA
AQR Arbitrage
Connecticut
+$51M
4
FCM
Farallon Capital Management
California
+$44.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$38.7M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$87.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$81.4M
3
GPP
Great Point Partners
Connecticut
-$69.8M
4
BG
Bellevue Group
Switzerland
-$53.2M
5
O
OrbiMed
New York
-$44.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
101
Ameriprise
Minnesota
$2.8M +$1.47M +39,106 +513%
PAMP
102
Polar Asset Management Partners
Ontario, Canada
$2.69M +$1.69M +45,000 New
WRBC
103
W.R. Berkley Corp
Connecticut
$2.62M +$1.64M +43,800 New
New York State Common Retirement Fund
104
New York State Common Retirement Fund
New York
$2.42M -$297K -7,900 -16%
PP
105
PDT Partners
New York
$2.41M -$739K -19,702 -33%
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
$2.26M +$1.16M +30,981 +454%
Voloridge Investment Management
107
Voloridge Investment Management
Florida
$2.23M +$1.04M +27,683 +286%
SCM
108
Stevens Capital Management
Pennsylvania
$2.1M +$1.32M +35,046 New
CC
109
Centiva Capital
New York
$2.09M +$1.31M +35,000 New
VI
110
Vestcor Inc
New Brunswick, Canada
$2.09M +$1.31M +35,000 New
UBS AM
111
UBS AM
Illinois
$2.08M -$9.41M -250,714 -88%
Deutsche Bank
112
Deutsche Bank
Germany
$1.98M -$3.58M -95,438 -74%
AC
113
Athanor Capital
New York
$1.79M +$1.13M +30,000 New
DCM
114
Dupont Capital Management
Delaware
$1.73M -$477K -12,696 -31%
AIG
115
American International Group
New York
$1.69M -$8.89K -237 -0.8%
TOPU
116
Trustees of Princeton University
New Jersey
$1.65M +$1.03M +27,522 New
Walleye Capital
117
Walleye Capital
New York
$1.63M +$1.02M +27,310 New
Manulife (Manufacturers Life Insurance)
118
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.62M -$17.2K -459 -2%
HA
119
Havens Advisors
New York
$1.59M +$997K +26,572 New
AQR Capital Management
120
AQR Capital Management
Connecticut
$1.55M +$975K +25,973 New
KPF
121
K2 Principal Fund
Ontario, Canada
$1.54M +$964K +25,680 New
GCL
122
Glazer Capital LLC
New York
$1.5M +$938K +25,000 New
GI
123
GAMCO Investors
Connecticut
$1.49M +$934K +24,893 New
EVM
124
Eaton Vance Management
Massachusetts
$1.44M – – –
VOYA Investment Management
125
VOYA Investment Management
Georgia
$1.34M +$208K +5,535 +33%
3 4
5
6 7

BOLD Hedge Fund Activity: Q4 2019 in Review

188 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q4 2019, worth a combined $2.57B — up 105% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new BOLD positions and 46 closed out — a net gain of 40 holders — while 47 added to existing stakes and 39 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $59.8M. The largest seller was Redmile Group, cutting an estimated $87.2M.

  • 188 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q4 2019, up from 149 in Q3 2019.
  • Funds reported $2.57B of Audentes Therapeutics, Inc stock for Q4 2019, up 105% quarter-over-quarter.
  • 86 funds opened new Audentes Therapeutics, Inc positions in Q4 2019 and 46 closed out, a net change of +40 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q4 2019 was Magnetar Financial, an estimated $59.8M added.
  • The largest Audentes Therapeutics, Inc seller in Q4 2019 was Redmile Group, an estimated $87.2M sold.

Based on aggregated 13F filings for Q4 2019.